1. "Howard Scher"
  2. "2007"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (16)
  3. Book Section (1)
Groups
  1. Department of Medicine (36)
  2. Genitourinary Oncology Service (36)
  3. Solid Tumor Oncology Division (36)
  4. Epidemiology and Biostatistics (13)
  5. Biostatistics Service (12)
  6. GSK Faculty (9)

More Groups

People
  1. Howard Scher (36)
  2. Michael Morris (12)
  3. Glenn Heller (8)
  4. Susan Slovin (8)
  5. Steven Larson (6)
  6. David Solit (5)

More People

Years
  1. 2007 (36)
Publications
  1. Journal of Clinical Oncology (12)
  2. Clinical Cancer Research (6)
  3. Molecular Cancer Therapeutics (4)
  4. Cancer Research (2)
  5. Campbell-Walsh Urology. 9th ed (1)
  6. Cancer Immunology, Immunotherapy (1)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. American Society of Clinical Oncology (12)
  3. Elsevier Science, Inc. (2)
  4. Nature Publishing Group (2)
  5. Springer (2)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Prostate Cancer Clinical Trials Working Group (PCCTWG) consensus criteria for phase II clinical trials for castration-resistant prostate cancer
    Meeting Abstract

    Scher, H. I.; Halabi, S.; Tannock, I.; Morris, M.; Higano, C.; Kelly, W.; Sternberg, C.; Eisenberger, M.; Martin, A.; Hussain, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II trial of rapid androgen cycling and docetaxel (Doc) in prostate cancer patients with a rising prostate-specific antigen (PSA) in the noncastrate state
    Meeting Abstract

    Rathkopf, D. E.; Carducci, M. A.; Slovin, S.; Morris, M. J.; Kelsen, M.; Pili, R.; Denmeade, S. R.; Eisenberger, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of docetaxel and (153)Sm repetitively administered for castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Amodio, A. J.; Gignac, G. A.; Flatts, E.; Slovin, S.; Solit, D.; Rathkopf, D.; Larson, S.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Different chromosomal alterations correlate with gene expression in African American (AA) versus Caucasian American (CA) prostate cancer (PC) patients
    Meeting Abstract

    Jean-Gilles, J. Jr; Satagopan, J.; Zhou, Q.; Dash, A.; Yu, J.; Lee, P.; Scher, H. I.; Gerald, W.; Osman, I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Suberoylanilide hydroxamic acid (vorinostat) post chemotherapy in hormone refractory prostate cancer (HRPC) patients (pts): A phase II trial by the Prostate Cancer Clinical Trials Consortium (NCI 6862)
    Meeting Abstract

    Hussain, M.; Dunn, R.; Rathkopf, D.; Stadler, W.; Wilding, G.; Smith, D. C.; Bradley, D.; Cooney, K. A.; Zweibel, J.; Scher, H.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A novel intermediate endpoint for predicting overall survival in men with metastatic castration-recurrent prostate cancer (CRPC)
    Meeting Abstract

    Halabi, S.; Ou, S.; Vogelzang, N. J.; Scher, H.; Small, E. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A physiologically-based pharmacokinetic (PBPK) and pharmacodynamic (PD) model of docetaxel (Doc) and neutropenia in humans
    Meeting Abstract

    Florian, J. A. Jr; Egorin, M. J.; Zamboni, W. C.; Eiseman, J. L.; Lagattuta, T. F.; Belani, C. P.; Chatta, G. S.; Scher, H. I.; Solit, D. B.; Parker, R. S.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term toxicity monitoring via electronic patient reported outcomes in end-stage chemotherapy patients
    Meeting Abstract

    Basch, E. M.; Iasonos, A.; Barz, A.; Culkin, A.; Kris, M. G.; Artz, D.; Fearn, P.; Speakman, J.; Scher, H. I.; Schrag, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The clinical state of the rising PSA level after definitive local therapy: A practical approach
    Book Section

    Morris, M. J.; Scher, H. I.
    In Wein, A. J.; Kavoussi, L. R.; Novick, A. C.; Partin, A. W.; Peters, C. A. (Eds.) Campbell-Walsh Urology. 9th ed (2007)

    Fulltext@MSK | Save